Lorenzo Arnaboldi

1.9k total citations
40 papers, 1.5k citations indexed

About

Lorenzo Arnaboldi is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Lorenzo Arnaboldi has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 16 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Lorenzo Arnaboldi's work include Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (12 papers) and Plant biochemistry and biosynthesis (8 papers). Lorenzo Arnaboldi is often cited by papers focused on Lipoproteins and Cardiovascular Health (17 papers), Cancer, Lipids, and Metabolism (12 papers) and Plant biochemistry and biosynthesis (8 papers). Lorenzo Arnaboldi collaborates with scholars based in Italy, United States and France. Lorenzo Arnaboldi's co-authors include Alberto Corsini, Rodolfo Paoletti, Stefano Bellosta, Nicola Ferri, Franco Bernini, R. Fumagalli, Robert E. Pitas, M. Canavesi, P. Quarato and Scott Turner and has published in prestigious journals such as PLoS ONE, Hepatology and Hypertension.

In The Last Decade

Lorenzo Arnaboldi

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorenzo Arnaboldi Italy 20 755 435 327 313 268 40 1.5k
Anouar Hafiane Canada 21 821 1.1× 481 1.1× 509 1.6× 231 0.7× 345 1.3× 52 1.6k
Sally P.A. McCormick New Zealand 25 1.0k 1.3× 632 1.5× 437 1.3× 254 0.8× 382 1.4× 59 2.1k
Sònia Benı́tez Spain 24 727 1.0× 375 0.9× 348 1.1× 349 1.1× 210 0.8× 67 1.6k
Zhen-Yan Fu China 23 475 0.6× 502 1.2× 505 1.5× 201 0.6× 210 0.8× 131 1.7k
Min‐Ji Charng Taiwan 16 883 1.2× 486 1.1× 522 1.6× 202 0.6× 334 1.2× 40 2.3k
Cristina Dı́az-Jullien Spain 17 760 1.0× 535 1.2× 190 0.6× 128 0.4× 264 1.0× 28 1.6k
Koji Oida Japan 19 588 0.8× 355 0.8× 400 1.2× 185 0.6× 216 0.8× 51 1.5k
Annie St‐Pierre Canada 12 451 0.6× 510 1.2× 486 1.5× 189 0.6× 184 0.7× 22 1.4k
Hagai Tavori United States 24 1.2k 1.6× 369 0.8× 232 0.7× 142 0.5× 270 1.0× 47 1.8k
Masahiro Koseki Japan 19 468 0.6× 350 0.8× 371 1.1× 529 1.7× 139 0.5× 62 1.3k

Countries citing papers authored by Lorenzo Arnaboldi

Since Specialization
Citations

This map shows the geographic impact of Lorenzo Arnaboldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Arnaboldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Arnaboldi more than expected).

Fields of papers citing papers by Lorenzo Arnaboldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Arnaboldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Arnaboldi. The network helps show where Lorenzo Arnaboldi may publish in the future.

Co-authorship network of co-authors of Lorenzo Arnaboldi

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Arnaboldi. A scholar is included among the top collaborators of Lorenzo Arnaboldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Arnaboldi. Lorenzo Arnaboldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ponticelli, Claudio, et al.. (2024). How We Treat Dyslipidemia in Prolonged Nephrotic Syndrome. Clinical Journal of the American Society of Nephrology. 19(10). 1327–1329. 1 indexed citations
2.
Svecla, Monika, Lorenzo Da Dalt, Annalisa Moregola, et al.. (2024). ASGR1 deficiency diverts lipids toward adipose tissue but results in liver damage during obesity. Cardiovascular Diabetology. 23(1). 42–42. 6 indexed citations
3.
Valenza, Alice, et al.. (2023). A Drosophila model targets Eiger/TNFα to alleviate obesity-related insulin resistance and macrophage infiltration. Disease Models & Mechanisms. 16(11). 5 indexed citations
4.
Lazzarato, Loretta, Laura Bianchi, Annapaola Andolfo, et al.. (2023). Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms. Molecules. 28(15). 5724–5724. 3 indexed citations
5.
Arnaboldi, Lorenzo, Alice Ossoli, Livia Pisciotta, et al.. (2020). LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters. Atherosclerosis. 297. 8–15. 14 indexed citations
6.
Castiglioni, Silvia, Matteo Monti, Lorenzo Arnaboldi, et al.. (2017). The dataset describes: Phenotypic changes induced by cholesterol loading in smooth muscle cells isolated from the aortae of C57BL/6 mice. Data in Brief. 16. 334–340. 2 indexed citations
7.
Castiglioni, Silvia, Matteo Monti, Lorenzo Arnaboldi, et al.. (2017). ABCA1 and HDL 3 are required to modulate smooth muscle cells phenotypic switch after cholesterol loading. Atherosclerosis. 266. 8–15. 21 indexed citations
8.
Arnaboldi, Lorenzo & Alberto Corsini. (2015). Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. Atherosclerosis Supplements. 16. 1–27. 44 indexed citations
9.
Baetta, Roberta, Agnese Granata, Daniela Miglietta, et al.. (2013). Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol. Cardiovascular Drugs and Therapy. 27(3). 211–219. 7 indexed citations
10.
Zanotti, Ilaria, Francesca Zimetti, Francesco Potì, et al.. (2013). Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion. PLoS ONE. 8(8). e71572–e71572. 11 indexed citations
11.
Ciceri, Paola, et al.. (2011). Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiation. Nephrology Dialysis Transplantation. 27(1). 122–127. 44 indexed citations
12.
Arnaboldi, Lorenzo & Alberto Corsini. (2010). Do structural differences in statins correlate with clinical efficacy?. Current Opinion in Lipidology. 21(4). 298–304. 30 indexed citations
13.
Tibolla, G., Giuseppe Danilo Norata, Clara Meda, et al.. (2009). Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. Atherosclerosis. 210(1). 78–87. 47 indexed citations
14.
Arnaboldi, Lorenzo, Franco Pazzucconi, Giuseppe Radaelli, et al.. (2007). Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation. Pharmacological Research. 56(6). 503–508. 6 indexed citations
15.
Arnaboldi, Lorenzo, Jim Yan, Ray Kit Ng, et al.. (2006). Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. Journal of Lipid Research. 47(10). 2280–2290. 219 indexed citations
16.
Ferri, Nicola, Lorenzo Arnaboldi, Augusto Orlandi, et al.. (2001). Effect of S(−) perillic acid on protein prenylation and arterial smooth muscle cell proliferation☆2☆This research was partially supported by Institut of Recherches Internationales Servier, Paris, France. N. Ferri, L. Arnaboldi, and A. Corsini are also partially supported by a grant from the Ministero dell’Università e della Ricerca Scientifica e Tecnologica (cofinanziamento 1999, progetto “Role of smooth muscle cells in atherogenesis: pharmacological implications,” protocollo 9905157119. M. H. Gelb and K. Yokoyama are supported by a Grant from the National Institute of Health (CA 52874). A. Corsini is a visiting scientist under the terms of the US (National Heart, Lung, and Blood Institute)-Italy bilateral agreement in the cardiovascular area.2Abbreviations: FOH, farnesol; GGOH, geranylgeraniol; PFTase, protein farnesyltransferase; PGGTase, protein geranylgeranyltransferase; PA, perillic acid; SMC, smooth muscle cell; MVA, mevalonate; HMG-CoA, 3-hydroxy-3-methyl-glutaryl coenzyme A; FCS, fetal calf serum; MEM, Minimum Essential Medium; PBS, phosphate buffered saline; PI, propidium iodide.. Biochemical Pharmacology. 62(12). 1637–1645. 16 indexed citations
17.
Corsini, Alberto, Franco Pazzucconi, Lorenzo Arnaboldi, et al.. (1998). Direct Effects of Statins on the Vascular Wall. Journal of Cardiovascular Pharmacology. 31(5). 773–778. 77 indexed citations
18.
Raiteri, M., Lorenzo Arnaboldi, Paul McGeady, et al.. (1997). Pharmacological Control of the Mevalonate Pathway: Effect on Arterial Smooth Muscle Cell Proliferation. Journal of Pharmacology and Experimental Therapeutics. 281(3). 1144–1153. 83 indexed citations
19.
Raiteri, M., Lorenzo Arnaboldi, P. Quarato, et al.. (1995). [The pharmacology of the statins: the evidence of a direct antiatherosclerotic action].. PubMed. 10 Suppl. 35S–42S. 2 indexed citations
20.
Merkel, Carlo, Angelo Gatta, Lorenzo Arnaboldi, & R Zuin. (1985). Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clinical Physiology. 5(6). 531–539. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anouar Hafiane Breakdown of academic impact, for papers by Sally P.A. McCormick Breakdown of academic impact, for papers by Sònia Benı́tez Breakdown of academic impact, for papers by Zhen-Yan Fu Breakdown of academic impact, for papers by Min‐Ji Charng Breakdown of academic impact, for papers by Cristina Dı́az-Jullien Breakdown of academic impact, for papers by Koji Oida Breakdown of academic impact, for papers by Annie St‐Pierre Breakdown of academic impact, for papers by Hagai Tavori Breakdown of academic impact, for papers by Masahiro Koseki
Rankless by CCL
2026